December 29, 2023
A Journey Through Immunization History
Because we’ve seen a lot of antivax narratives, let’s just give you a brief history of immunization. A Journey Through…
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
November 15, 2023
Novo Nordisk plans investing more than 42 billion Danish kroner in kalundborg Denmark (€5.6B)
Novo Nordisk has said plans to invest more than 42 billion Danish kroner starting in 20231 to expand existing manufacturing facilities in Kalundborg, Denmark, for the current and future product portfolio within serious chronic diseases.
October 26, 2023
Medigene ends 3Q in line with financial expectations
Medigene has reported its financial performance in the third quarter of 2023 was in line with the Executive Management Board’s expectations, as the revenues in the third quarter 2023 amounted to EUR 1.6 million compared to EUR 1.4 million in the previous year period (9-month period 2023: EUR 4.6 million), primarily from the partnership with BioNTech.
October 24, 2023
Lonza launches two new rapid monocyte activation test (MAT) systems
Lonza has launched two new rapid monocyte activation test (MAT) systems, the PyroCell MAT Rapid System and PyroCell MAT Human Serum (HS) Rapid System, to streamline and simplify rabbit-free pyrogen testing.
October 24, 2023
Orphelia Pharma applies to EMA its drinkable temozolomide medication in the treatment of relapsed or refractory neuroblastoma
Orphelia Pharma, a pharmaceutical company focused on pediatric and orphan medicines, has filed a centralized Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for KIZFIZO, the first oral liquid formulation of temozolomide.
October 24, 2023
Idorsia posts net revenue 9M 2023 at CHF 131 million
Idorsia has announced its financial results for the first nine months of 2023, with net revenues at CHF 29 million, of which CHF 20 million net sales with QUVIVIQ in the US and Europe (Germany, Italy, Switzerland) and CHF 9 million contract revenues.
October 19, 2023
SOPHiA genetics with with Memorial Sloan Kettering Cancer Center (MSK), a top cancer treatment and research institution, and AstraZeneca have entered a collaboration to work on providing inclusive access to comprehensive cancer testing worldwide.
October 19, 2023
Xlife Sciences invests in 4D Lifetec
Xlife Sciences AG has invested CHF 23.3 million in 4D Lifetec AG , acquiring a 20% stake in the company.
October 19, 2023
Abivax issues shares between €10.98 and €12.30 per ordinary share
Abivax kicked off book-building and the filing of an amended registration statement on Form F-1, to issue approximately 20,325,500 ordinary shares
October 19, 2023
Basilea buys privately owned Gravitas Therapeutics for clinical-stage antifungal compound
Basilea Pharmaceutica has entered into an asset purchase agreement with privately owned Gravitas Therapeutics Inc. for GR-2397, a clinical-stage antifungal compound with a novel mechanism of action, targeting invasive mold infections caused by Aspergillus species.